⌘K

Login Start Free

Home/Filings/4/0001707797-25-000006

4//SEC Filing

Jain Rita 4

Accession 0001707797-25-000006

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:11 PM ET

Size

5.4 KB

Accession

0001707797-25-000006

Insider Transaction Report

Form 4

Period: 2025-09-30

Avalo Therapeutics, Inc.AVTX

Director

Transactions

Award
Stock Option (Right to Buy)
2025-09-30+1,572→ 1,572 total
Exercise: $12.71Exp: 2035-09-30→ Common Stock (1,572 underlying)

Footnotes (1)

[F1]The options were granted on September 30, 2025, and are 100% vested.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001707797

Filing Metadata

Form type: 4
Filed: Oct 1, 8:00 PM ET
Accepted: Oct 2, 4:11 PM ET
Size: 5.4 KB

View on SEC.gov